EBCC-4 is expected to attract about 4,000 delegates from around 80 countries worldwide. The conference covers the entire spectrum of breast cancer and highlights what is new across fields. EBBC-4 is the only forum in Europe that involves all the key players in breast cancer, and is unique in its partnership between clinicians and the patient advocacy community.

The radio show will address some of the key highlights of the meeting and feature information about the growing importance and role of aromatase inhibitors.

"European research has a significant impact on the course of breast cancer treatment and disease management, and global research efforts influence the clinical choices for many women worldwide. Vital Options is committed to its mission of facilitating a global cancer dialogue. International broadcasts from meetings like EBCC-4, allow us to bring vital and timely information directly to our listeners," says Selma Schimmel, host of The Group Room and Founder and CEO of Vital Options® International TeleSupport® Cancer Network, the southern California-based not-for-profit cancer communications, support and advocacy organization that produces the show in association with Premiere Radio Networks, the nation's largest radio network.

Joining Schimmel at the broadcast will be: Dr. Jacek Jassem, MD, PhD, Chairman of EBCC-4 and Professor of Clinical Oncology, Head, Department of Oncology and Radiotherapy, Medical University of Gdansk, Poland; Dr. Anne Appleton, Chief Physician, Breast Unit, Clinique de Genolier, Switzerland; Professor R Charles Coombes, MD PhD FRCP FMedSci, Head, Department of Cancer Medicine, Division of Medicine, Faculty of Medicine, Imperial College London, Director of Cancer Services & Haematology, Hammersmith Hospitals Trust, London, UK; Dr. Stefan Gluck, M.D., Ph.D., Professor of Medicine, Associate Clinical Director, Breast Cancer Program, The University of Miami School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA; Dr. Lars Holmberg, Professor of Clinical Cancer Epidemiology, Regional Oncology Centre of Uppsala University Hospital, Uppsala, Sweden; Dr. Clifford Hudis, MD, Chief, Breast Cancer Medicine Service, Memorial-Sloan Kettering Cancer Center, New York, NY, USA; and other leading breast cancer experts.

The Group Room airs live every Sunday in cities throughout the United States, reaching more than a half-million radio listeners a week, in addition to others who tune in via XM Satellite Radio or the Internet simulcast at www.vitaloptions.org where the show is also archived. Callers can enter discussions toll-free by dialing 1-800-GRP-ROOM (1-800-477-7666) or sending their comments and questions by email to info@vitaloptions.org.

The show features Schimmel and The Group Room's regular on-air medical experts--medical oncologist Dr. Michael Van Scoy-Mosher, radiation oncologist Dr. Leslie Botnick and therapist Halina Irving, MFCC--who are joined each week by callers affected by cancer, as well as renowned cancer experts and advocates who provide updates on research, medical advances, and advocacy efforts. All phone calls are screened by a licensed oncology social worker. During the week, individuals can reach Vital Options for additional support services and information.

Founded in 1983, Vital Options was the first organization to address issues related to young adults with cancer before expanding to include patients of all ages and issues and information related to everyone touched by cancer. The Group Room regularly produces remote location broadcasts from the world's leading oncology meetings, such as the annual American Society of Clinical Oncology (ASCO) and its European equivalents, ECCO/ESMO, and from preeminent cancer centers in the United States and Europe.

Vital Options and The Group Room are supported through educational grants from corporate sponsors Bristol-Myers Squibb Co., Ortho Biotech Products, L.P., and Pfizer Oncology. This remote broadcast from EBCC-4 has been made possible through additional support from Novartis Oncology.